Jump Financial’s Capricor Therapeutics CAPR Stock Holding History

Jump Financial’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$555K	Buy	+23,036	New	+$698K	﹤0.01%	1418
2026 Q1	–	Sell	-49,500	Closed	-$1.43M	–	1939
2025 Q4	$1.43M	Buy	+49,500	New	+$646K	0.02%	830
2025 Q3	–	Sell	-232,536	Closed	-$2.31M	–	1830
2025 Q2	$2.31M	Buy	232,536 +69,515	+43%	+$734K	0.03%	676
2025 Q1	$1.55M	Buy	+163,021	New	+$2.26M	0.02%	671
2024 Q3	–	Sell	-52,100	Closed	-$249K	–	1677
2024 Q2	$249K	Sell	52,100 -3,813	-7%	-$21.3K	0.01%	1459
2024 Q1	$380K	Buy	55,913 +3,113	+6%	+$15.1K	0.01%	1326
2023 Q4	$258K	Buy	+52,800	New	+$172K	0.01%	1419
2023 Q1	–	Sell	-14,595	Closed	-$56.3K	–	1630
2022 Q4	$56.3K	Sell	14,595 -8,005	-35%	-$38.2K	﹤0.01%	1489
2022 Q3	$136K	Buy	+22,600	New	+$116K	0.01%	1411
2022 Q1	–	Sell	-22,800	Closed	-$67K	–	1574
2021 Q4	$67K	Buy	+22,800	New	+$79.9K	﹤0.01%	1275

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jump Financial's CAPR Position: Q2 2026 in Review

Jump Financial opened a new position in Capricor Therapeutics (CAPR) in Q2 2026: 23,036 shares worth $555K. The stake represents ﹤0.01% of the portfolio and ranks #1418 among its holdings. This is a return to the name: Jump Financial previously reported a position in CAPR as recently as Q4 2025.

Jump Financial first reported a position in CAPR in Q4 2021 and has held it in 10 quarters since. The position peaked at $2.31M in Q2 2025. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

Jump Financial held 23,036 shares of Capricor Therapeutics worth $555K as of Q2 2026.
Capricor Therapeutics was a new Jump Financial position in Q2 2026.
Capricor Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1418 holding.
Jump Financial first reported a position in Capricor Therapeutics in Q4 2021 and has held it in 10 quarters since.
Jump Financial's Capricor Therapeutics position peaked at $2.31M in Q2 2025.
170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.